Except for the 8 peer reviewed articles that challenge the legitimacy of the clinical trial revisions done 2 weeks before the completion of the trial.
Totally new comparator (one required to be approve BEFORE the trial started), change the protocol, endpoints, and experimental design. All were well detailing in these publications.
Market Data 
Markets 
AI
